IP Verse

Unitary Combination Of Fsh And Hcg - EP2292252

The patent EP2292252 was granted to Ferring on Aug 7, 2019. The application was originally filed on Jun 2, 2004 under application number EP10075419A. The patent is currently recorded with a legal status of "Revoked".

EP2292252

FERRING
Application Number
EP10075419A
Filing Date
Jun 2, 2004
Status
Revoked
Jun 30, 2023
Grant Date
Aug 7, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MERCK SERONOMay 5, 2020WEICKMANN & WEICKMANN PARTMBBADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS5929028
DESCRIPTIONWO0067778
DESCRIPTIONWO8604589
OPPOSITIONEP0448146
OPPOSITIONEP1285665
OPPOSITIONEP1364658
OPPOSITIONEP1633389
OPPOSITIONWO0067778
OPPOSITIONWO03022302
OPPOSITIONWO2004105788
OPPOSITIONWO9425005
SEARCHWO0067778
SEARCHWO03022302

Non-Patent Literature (NPL) Citations (33) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ASCOLI, ENDOCRINOLOGY, (1981), vol. 108, page 88-
DESCRIPTION- CAMPBELL ET AL., J. REPROD. FERTIL., (1999), vol. 117, page 244-
DESCRIPTION- CHANG ET AL., FERTIL. STERIL., (2001), vol. 76, page 67-
DESCRIPTION- CHAPPEL ET AL., ENDOCRINE REVIEWS, (1983), vol. 4, page 179-
DESCRIPTION- CLAESSON ET AL., ACTA ENDOCRINOL., (1948), vol. 1, page 1-
DESCRIPTION- DIGHE; MOUDGAL, ARCH. BIOCHEM. BIOPHYS., (1983), vol. 225, page 490-
DESCRIPTION- FERTIL. STERIL., (2001), vol. 75, page 1111-
DESCRIPTION- FEVOLD ET AL., ENDOCRINOLOGY, (1940), vol. 26, page 999-
DESCRIPTION- FILICORI ET AL., HUMAN REPROD., (2002), vol. 17, page 2009-
DESCRIPTION- FILICORI ET AL., HUMAN REPROD. UPDATE, (2002), vol. 8, page 543,552-
DESCRIPTION- FILICORI ET AL., J. CLIN. ENDOCRINOL. & METABOL., (1999), vol. 84, page 2659-
DESCRIPTION- FILICORI, FERTIL. STERIL., (2003), vol. 79, page 253-
DESCRIPTION- FRAENKEL-CONRAT ET AL., PROC. SOC. EXP. BIOL. MED., (1940), vol. 45, page 627-
DESCRIPTION- GUPTA; DIGHE, J. MOL. ENDOCRINOLOGY, (1999), vol. 22, page 273-
DESCRIPTION- HILLIER ET AL., MOL. CELL ENDOCRINOL., (1994), vol. 100, page 51-
DESCRIPTION- HUMAN REPROD., (1997), vol. 12, no. 1, page 52-
DESCRIPTION- KEENE ET AL., J. BIOL. CHEM., (1989), vol. 26, page 4769-
DESCRIPTION- LI ET AL., SCIENCE, (1949), vol. 109, page 445-
DESCRIPTION- MARTIN ET AL., FERTIL. STERIL., (2002), vol. 76, pages 0 - 49-
DESCRIPTION- MCSHAN; MEYER, J. BIOL. CHEM., (1940), vol. 135, page 473-
DESCRIPTION- REMINGTON'S PHARMACEUTICAL SCIENCES, 15th Ed., MACK PUBLISHING CO., (1975), pages 1405-12 - 1461-87-
DESCRIPTION- SHOHAM, FERTIL. STERIL., (2002), vol. 70, page 1170-
DESCRIPTION- SNYDER ET AL., MOL. CELL. ENDOCRIN., (1987), vol. 54, page 115-
DESCRIPTION- THE SCIENCE AND PRACTICE OF PHARMACY, pages 780 - 820-
DESCRIPTION- VAN HELL ET AL., ACTA ENDOCRIN., (1964), vol. 47, page 409-
DESCRIPTION- ZONDEK; ASCHHEIM, KLIN. WOCHENSCHR., (1928), vol. 7, page 931-
OPPOSITION- GIUDICE et al., "Characterisation of a partially purified human menopausal gonadotropin preparation", Journal of Clinical Research, (20010100), vol. 4, no. 27, pages 27 - 33, XP055698704-
OPPOSITION- VAN DEN HOOVEN et al., "Compositional analyses of a human menopausal gonadotrophin preparation extracted from urine (menotropin). Identification of some of its major impurities", RBM, (20030101), vol. 7, no. 5, pages 547 - 557, XP027052221-
OPPOSITION- THOMPSON et al., "Gonadotropin requirements of the developing follicle", Fertility and Sterility, (19950200), vol. 63, no. 2, pages 273 - 276, XP029530907
OPPOSITION- FILICORI et al., "Luteinizing Hormone Activity Supplementation Enhances Follicle-Stimulating Hormone Efficacy andImproves Ovulation Induction Outcome", The Journal of Clinical Endocrinology & Metabolism, (19990801), vol. 84, no. 8, pages 2659 - 2663, XP001055466
SEARCH- THOMPSON K A ET AL, "GONADOTROPHIN REQUIREMENTS OF THE DEVELOPING FOLLICLE", FERTILITY AND STERILITY, ELSEVIER SCIENCE INC, NEW YORK, NY, US, (199502), vol. 63, no. 2, ISSN 0015-0282, pages 273 - 276, XP001064790 [A] 1-14 * page 274, column 1, paragraph 3 *-
SEARCH- FILICORI M ET AL, "LUTEINIZING HORMONE ACTIVITY SUPPLEMENTATION ENHANCES FOLLICLE-STIMULATING HORMONE EFFICACY AND IMPROVES OVULATION INDUCTION OUTCOME", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, NEW YORK, NY, US, (199908), vol. 84, no. 8, ISSN 0021-972X, pages 2659 - 2663, XP001055466 [XD] 1-14 * page 1157, column 1; table 1 * * page 1158 *
SEARCH- FILICORI M ET AL, STIMULATION AND GROWTH OF ANTRAL OVARIAN FILLICLES BY SELECTIVE LH ACTIVITY ADMINISTRATION IN WOMEN, JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, NEW YORK, NY, US, PAGE(S) 1156-1161, (200203), ISSN 0021-972X, XP008004363 [XD] 1-14 * page 1660, column 1; table 1 * * page 2662, column 2, paragraph 3 - page 2663, column 1, paragraph 1 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents